-
Gut microbiota remodeling in infection and inflammation
Eun-Kyeong Jo Chungnam National University, Republic of Korea 13:00~14:30 -
Intermittent fasting as a nutritional intervention to modulate macrophage polarization for vascular health
Kyoung-Han Kim University of Ottawa, Canada 13:20~13:40 -
Spatiotemporal immune activation drives metabolic quiescence in brown adipose tissue
Su Myung Jung Sungkyunkwan University, Republic of Korea 13:40~14:00 - Panel Discussion 14:00~14:30
-
Choosing the right combination therapy: statin, ezetimibe, PCSK9 inhibitor, or beyond?
TBD (Name) TBD (Affiliation, Country) 16:10~16:28 -
Korean Fact Sheet: Current status of LDL-C control and cardiovascular risk
Ye Seul Yang Seoul National University, Republic of Korea 16:28~16:46 -
Korean Fact Sheet: Real-world utilization of lipid lowering agents
Kyu Ho Kim The Catholic University of Korea, Republic of Korea 16:46~17:04 -
Why are LDL-C targets still unmet? common errors and practical solutions in the clinic
Sang Yeub Lee Chung-Ang University, Republic of Korea 17:04~17:22 - Panel Discussion 17:22~17:40
Chairperson(s) : Hack-Lyoung Kim (Seoul National University, Republic of Korea)
-
Sex differences in lipid profiles and residual cardiovascular risk
Soo Jin Kim Kosin University, Republic of Korea 12:45~13:00 -
Early-onset dyslipidemia in young adults: screening strategies and lifetime ASCVD risk assessment
Jaehyun Bae Hallym University, Republic of Korea 13:00~13:15 -
Menopause and cardiometabolic transition: optimizing lipid management in midlife women
In Jeong Cho Ewha Womans University, Republic of Korea 13:15~13:30 - Panel Discussion 13:30~13:45
-
Korean epidemiology and risk modifiers for establishing LDL-C goal strategies
Jong Han Choi Konkuk University, Republic of Korea 13:45~14:03 -
Practical algorithm for intensive lipid lowering therapy in the 2026 Korean guidelines
Jaehoon Chung Gachon University, Republic of Korea 14:03~14:21 -
Nutritional management and lifestyle modification tailored to the Korean dietary pattern
Ga Ram Cho Hannam University, Republic of Korea 14:21~14:39 -
Optimized lipid management for special populations
Byung Sik Kim Hanyang University, Republic of Korea 14:39~14:57 - Panel Discussion 14:57~15:15
-
PCSK9 inhibition in primary prevention: insights from VESALIUS-CV and clinical implications
Doo Sun Sim Chonnam National University, Republic of Korea 16:10~16:30 -
Low LDL-C and brain safety: risk of hemorrhagic stroke and cognitive dysfunction
Kwang-Yeol Park Chung-Ang University, Republic of Korea 16:30~16:50 -
Early combination therapy in primary prevention
Hoyoun Won Chung-Ang University, Republic of Korea 16:50~17:10 - Panel Discussion 17:10~17:40
-
Residual cardiovascular risk in hypertension despite optimal BP control
Hyue Mee Kim Chung-Ang University, Republic of Korea 13:00~13:15 -
Lipid management in hypertensive patients
Jaehoon Chung Gachon University, Republic of Korea 13:15~13:30 -
Obesity, insulin resistance, and hypertension-related vascular injury
Mi Hye Seo Soonchunhyang University, Republic of Korea 13:30~13:45 - Panel Discussion 13:45~14:00
-
Cardiologist perspective: implementing novel cardiometabolic therapies in CVD
Donna Shu-Han Lin Shin Kong Wu Ho-Su Memorial Hospital, Taiwan 14:10~14:30 -
Nephrologist’s perspective: kidney protection strategies to improve cardio-kidney outcomes
Jong Hyun Jhee Yonsei University, Republic of Korea 14:30~14:50 -
Endocrinologist perspective: optimizing combination therapy in complex CKM patients
Jae-Seung Yun The Catholic University of Korea, Republic of Korea 14:50~15:10 - Panel Discussion 15:10~15:40
-
Brain GPCR targets and circuits controlling food intake
So Young Kwak Kyungpook National University, Republic of Korea 15:40~16:00 -
Understanding gene-diet interactions in cardiometabolic health
Sun Min Park Hoseo University, Republic of Korea 16:00~16:20 -
Interaction effects of genetic variants and dietary intake on the development of metabolic syndrome
Dayeon Shin Ewha Womans University, Republic of Korea 16:20~16:40 - Panel Discussion 16:40~17:10
